CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-02 | Gallman Cari EVP, General Counsel | Option exercise | +4,558 | 13,398 | ||
| 2025-10-02 | Gallman Cari EVP, General Counsel | Shares withheld for taxes | −2,332 | $45.73 | $107K | 11,066 |
| 2025-10-02 | Gallman Cari EVP, General Counsel | Option exercise · Restricted Stock Units | −4,558 | 4,559 | ||
| 2025-09-30 | Samuels Theodore R. II Director | Grant or award · Deferred Share Units | +1,108.65 | 61,419.6 | ||
| 2025-09-30 | McMullen Michael R. Director | Grant or award · Deferred Share Units | +776.05 | 10,076.28 | ||
| 2025-09-30 | Rice Derica W Director | Grant or award · Deferred Share Units | +831.49 | 33,784.28 | ||
| 2025-09-30 | Arduini Peter J Director | Grant or award · Deferred Share Units | +748.34 | 64,620.16 | ||
| 2025-09-30 | YALE PHYLLIS R Director | Grant or award · Deferred Share Units | +776.05 | 37,734.69 | ||
| 2025-09-02 | Elkins David V EVP, Chief Financial Officer | Sale | −56,000 | $47.33 | $2.7M | 167,379 |
| 2025-09-01 | Short Bartie Wendy EVP, Corporate Affairs | Option exercise | +1,235 | 6,301 | ||
| 2025-09-01 | Short Bartie Wendy EVP, Corporate Affairs | Shares withheld for taxes | −632 | $47.18 | $30K | 5,669 |
| 2025-09-01 | Short Bartie Wendy EVP, Corporate Affairs | Option exercise · Restricted Stock Units | −1,235 | 1,236 | ||
| 2025-08-02 | Short Bartie Wendy EVP, Corporate Affairs | Option exercise | +738 | 5,444 | ||
| 2025-08-02 | Short Bartie Wendy EVP, Corporate Affairs | Sale | −378 | $44.23 | $17K | 5,066 |
| 2025-08-02 | Short Bartie Wendy EVP, Corporate Affairs | Option exercise · Restricted Stock Units | −738 | 0 | ||
| 2025-08-01 | Massacesi Cristian EVP,Chief Med Offr,Head of Dev | Grant or award · Restricted Stock Units | +204,691 | 204,691 | ||
| 2025-08-01 | Gallman Cari EVP, General Counsel | Option exercise | +1,061 | 9,383 | ||
| 2025-08-01 | Gallman Cari EVP, General Counsel | Shares withheld for taxes | −543 | $44.23 | $24K | 8,840 |
| 2025-08-01 | Gallman Cari EVP, General Counsel | Option exercise · Restricted Stock Units | −1,061 | 1,061 | ||
| 2025-07-01 | Shibutani Hiroshi Chris EVP, Chief Strategy Officer | Grant or award · Restricted Stock Units | +12,810 | 12,810 |
Page 14 of 40 · 799 trades